Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation

M A Karsdal1, I Byrjalsen, D J Leeming

  • 1Nordic Bioscience A/S, Herlev, Denmark. mk@nordicbioscience.com

Abstract

Insights

Tibolone significantly reduced bone resorption in postmenopausal women but did not affect cartilage degradation. This suggests an uncoupling of bone and cartilage effects for this synthetic steroid.

Area of Science:

  • Endocrinology
  • Rheumatology
  • Pharmacology

Background:

  • Osteoarthritis involves increased bone resorption and cartilage degradation.
  • Tibolone is a synthetic steroid with multiple hormonal properties.

Purpose of the Study:

  • To investigate Tibolone's dual action on bone and cartilage turnover.
  • To compare Tibolone's effects with Selective Estrogen Receptor Modulators (SERMs) and Hormone Replacement Therapy (HRT).

Main Methods:

  • Secondary analysis of a 2-year randomized, placebo-controlled trial.
  • 91 healthy postmenopausal women received Tibolone (1.25 or 2.5 mg/day) or placebo.
  • Urine samples analyzed for bone resorption (CTX-I) and cartilage degradation (CTX-II) markers.

Main Results:

  • Tibolone significantly suppressed bone resorption by approximately 60% (P < 0.001).
  • No significant effect of Tibolone on cartilage degradation was observed.

Conclusions:

  • Tibolone demonstrates an uncoupling of bone and cartilage effects.
  • Bone resorption is decreased, while cartilage degradation remains unchanged.
  • Tibolone's complex pharmacology may explain these distinct effects on bone and cartilage.

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...